🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.

Experimental Drug Gaining Traction Online

The experimental drug, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are encouraged to contact these accounts privately for source information, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where communities with numerous of members share “before and after” images, administration instructions and claims of rapid UK delivery. Sellers promote the drug there before directing customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Professionals Express Worries

Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unapproved medication in the UK is a cause for concern and could lead to individuals injecting products of unknown origin.

Some experts stated the popularity for the experimental drug could be connected to the rising price of licensed slimming products such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to fines, legal action or imprisonment.

Service Reaction and Content Elimination

Based on the social media company, the service has removed problematic material and banned associated hashtags and search suggestions. The organization said it was dedicated to maintaining the platform secure and investing in strengthening enforcement strategies.

Digital Marketplace Activities

Investigations also found communities with up to nine thousand members selling the experimental drug using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up groups with thousands of users, filled with images of slimming results, glowing reviews and step-by-step instructions for preparing or administering at residence.

After minutes of entering one group, a seller shared WhatsApp details, where the majority of purchases take place. The seller provided an guidebook and promised shipping within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one inquired about weight, medical conditions or previous experience.

Product Information and Pricing

Within these groups, posts show black plastic packages with postal service stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When questioned how much time a injector should last, vendors give conflicting answers varying between a several days to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service said it actively moderated harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting substances they can’t verify. Although the research behind retatrutide is sound, these online products may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service linked the surge in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.

Her team has previously seen patients injured by self-injection from unverified sources. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company experimental product not yet approved … may expose patients to possibly significant health risks”.